{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:22:01Z","timestamp":1792174921385,"version":"4.4.0"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.7445","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T13:00:58Z","timestamp":1591189258000},"page":"e207445","source":"Crossref","is-referenced-by-count":24,"title":["Regional Disparities in Qualified Health Plans\u2019 Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States"],"prefix":"10.1001","volume":"3","author":[{"given":"Kathleen A.","family":"McManus","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and International Health, University of Virginia, Charlottesville"},{"name":"Center for Health Policy, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Powers","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Killelea","sequence":"additional","affiliation":[{"name":"Health Systems and Policy, NASTAD, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Tello-Trillo","sequence":"additional","affiliation":[{"name":"Center for Health Policy, University of Virginia, Charlottesville"},{"name":"Batten School of Leadership and Public Policy, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rogawski McQuade","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, University of Virginia, Charlottesville"},{"name":"Department of Public Health Sciences, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"27","key":"zoi200324r1","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi200324r2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-156-8-201204170-00001","article-title":"The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.","volume":"156","author":"Juusola","year":"2012","journal-title":"Ann Intern Med"},{"issue":"9","key":"zoi200324r3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States.","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"issue":"12","key":"zoi200324r4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV preexposure prophylaxis: a review.","volume":"319","author":"Riddell","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"zoi200324r5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/QAI.0b013e3182973966","article-title":"Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care.","volume":"64","author":"Farnham","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"zoi200324r6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annepidem.2018.06.009","article-title":"Trends in the use of oral emtricitabine\/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.","volume":"28","author":"Sullivan","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"12","key":"zoi200324r7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","article-title":"The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis\u2013to-need ratio in the fourth quarter of 2017, United States.","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"1","key":"zoi200324r8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/QAI.0000000000001165","article-title":"Brief report: the right people, right places, and right practices: disparities in PrEP access among African American men, women, and MSM in the Deep South.","volume":"74","author":"Elopre","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"zoi200324r9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.contraception.2015.12.018","article-title":"United States family planning providers\u2019 knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.","volume":"93","author":"Seidman","year":"2016","journal-title":"Contraception"},{"issue":"3","key":"zoi200324r10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s11606-019-05475-9","article-title":"Roadblocks to PrEP: what medical records reveal about access to HIV pre-exposure prophylaxis.","volume":"35","author":"Skolnik","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"5","key":"zoi200324r11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s10461-017-1690-0","article-title":"Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men.","volume":"21","author":"Eaton","year":"2017","journal-title":"AIDS Behav"},{"key":"zoi200324r12","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1136\/sextrans-2016-052581","article-title":"O02.4: It\u2019s just not for me: exploring low PrEP uptake among young black men who have sex with men in the Southern United States.","volume":"93","author":"Pingel","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"4","key":"zoi200324r13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11904-019-00447-4","article-title":"Implementation strategies to increase PrEP uptake in the South.","volume":"16","author":"Sullivan","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"zoi200324r14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1570162X16666180730144455","article-title":"Structural barriers to pre-exposure prophylaxis use among young sexual minority men: the P18 cohort study.","volume":"16","author":"Jaiswal","year":"2018","journal-title":"Curr HIV Res"},{"issue":"2","key":"zoi200324r15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/apc.2014.0142","article-title":"Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.","volume":"29","author":"Auerbach","year":"2015","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"zoi200324r16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/apc.2019.0189","article-title":"Health care provider barriers to HIV pre-exposure prophylaxis in the United States: a systematic review.","volume":"34","author":"Pleuhs","year":"2020","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"zoi200324r17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2105\/AJPH.2019.305389","article-title":"Is insurance a barrier to HIV preexposure prophylaxis? clarifying the issue.","volume":"110","author":"Kay","year":"2020","journal-title":"Am J Public Health"},{"issue":"5","key":"zoi200324r20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/QAI.0000000000001532","article-title":"Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States, 2015.","volume":"76","author":"Smith","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"zoi200324r22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMp1411376","article-title":"Using drugs to discriminate: adverse selection in the insurance marketplace.","volume":"372","author":"Jacobs","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi200324r24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157324","article-title":"Putting PrEP into practice: lessons learned from early-adopting U.S. providers\u2019 firsthand experiences providing HIV pre-exposure prophylaxis and associated care.","volume":"11","author":"Calabrese","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"zoi200324r25","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","article-title":"PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists.","volume":"21","author":"Petroll","year":"2017","journal-title":"AIDS Behav"},{"issue":"1","key":"zoi200324r27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1377\/hlthaff.23.1.135","article-title":"Benefits and risks of increasing restrictions on access to costly drugs in Medicaid.","volume":"23","author":"Soumerai","year":"2004","journal-title":"Health Aff (Millwood)"},{"issue":"8","key":"zoi200324r28","first-page":"893","article-title":"The effect of formulary restrictions on patient and payer outcomes: a systematic literature review.","volume":"23","author":"Park","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"zoi200324r36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.annepidem.2017.02.003","article-title":"Lifetime risk of a diagnosis of HIV infection in the United States.","volume":"27","author":"Hess","year":"2017","journal-title":"Ann Epidemiol"},{"issue":"7","key":"zoi200324r37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/QAD.0000000000000622","article-title":"State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States.","volume":"29","author":"Oldenburg","year":"2015","journal-title":"AIDS"},{"issue":"6","key":"zoi200324r38","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10461-013-0687-6","article-title":"HIV-related stigma among African-American youth in the Northeast and Southeast US.","volume":"18","author":"Kerr","year":"2014","journal-title":"AIDS Behav"},{"issue":"11","key":"zoi200324r39","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1080\/09540121.2017.1300633","article-title":"Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts.","volume":"29","author":"Cahill","year":"2017","journal-title":"AIDS Care"},{"issue":"2","key":"zoi200324r40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172354","article-title":"Social, structural, behavioral and clinical factors influencing retention in pre-exposure prophylaxis (PrEP) care in Mississippi.","volume":"12","author":"Arnold","year":"2017","journal-title":"PLoS One"},{"issue":"24","key":"zoi200324r41","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJM199506153322406","article-title":"Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients.","volume":"332","author":"Smalley","year":"1995","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi200324r43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/ajhp\/zxy083","article-title":"Understanding the medication prior-authorization process: a case study of patients and clinical staff from a large rural integrated health delivery system.","volume":"76","author":"Jones","year":"2019","journal-title":"Am J Health Syst Pharm"},{"key":"zoi200324r44","article-title":"Refocusing medication prior authorization on its intended purpose.","author":"Resneck","journal-title":"JAMA"},{"issue":"10","key":"zoi200324r46","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25399","article-title":"Lack of health insurance is associated with delays in PrEP initiation among young black men who have sex with men in Atlanta, US: a longitudinal cohort study.","volume":"22","author":"Serota","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"zoi200324r51","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1377\/hlthaff.2015.0548","article-title":"Insurer competition in federally run marketplaces is associated with lower premiums.","volume":"34","author":"Jacobs","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"zoi200324r52","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/jamainternmed.2017.4780","article-title":"Association between number of insurers and premium rates in the Affordable Care Act Marketplace.","volume":"177","author":"Zhu","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"8","key":"zoi200324r53","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1377\/hlthaff.2018.0054","article-title":"ACA Marketplace premiums grew more rapidly in areas with monopoly insurers than in areas with more competition.","volume":"37","author":"Parys","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"zoi200324r54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing: associations with medication and medical utilization and spending and health.","volume":"298","author":"Goldman","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"zoi200324r55","first-page":"433","article-title":"Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.","volume":"22","author":"Thornton Snider","year":"2016","journal-title":"Am J Manag Care"},{"issue":"184","key":"zoi200324r56","first-page":"1","article-title":"Strategies used by adults to reduce their prescription drug costs: United States, 2013.","author":"Cohen","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"151","key":"zoi200324r57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.","volume":"4","author":"Anderson","year":"2012","journal-title":"Sci Transl Med"},{"issue":"1","key":"zoi200324r58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/jiw077","article-title":"A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine.","volume":"214","author":"Cottrell","year":"2016","journal-title":"J Infect Dis"},{"issue":"26","key":"zoi200324r59","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1056\/NEJMp1912293","article-title":"Preparing to end the HIV epidemic: California\u2019s route as a road map for the United States.","volume":"381","author":"Kazi","year":"2019","journal-title":"N Engl J Med"},{"key":"zoi200324r18"},{"key":"zoi200324r23","author":"Lee","year":"2017"},{"key":"zoi200324r19","unstructured":"Kaiser Family Foundation. Marketplace enrollment, 2014-2020. Accessed April 24, 2020. https:\/\/www.kff.org\/health-reform\/state-indicator\/marketplace-enrollment\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D"},{"key":"zoi200324r21","unstructured":"National Health Law Program. NHeLP and The AIDS Institute Complaint to HHS Re HIV\/AIDS Discrimination by FL. Published May 28, 2014. Accessed December 17, 2019. https:\/\/healthlaw.org\/resource\/nhelp-and-the-aids-institute-complaint-to-hhs-re-hiv-aids-discrimination-by-fl\/"},{"key":"zoi200324r26","unstructured":"HealthCare.gov. Prior authorization. Accessed January 20, 2020. https:\/\/www.healthcare.gov\/glossary\/prior-authorization\/"},{"key":"zoi200324r29","unstructured":"US Food and Drug Administration. FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. October 3, 2019. Accessed December 13, 2019. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic"},{"key":"zoi200324r30","unstructured":"US Census Bureau. Geographic Areas Reference Manual (GARM). Last revised May 16, 2018. Accessed July 16, 2019. https:\/\/www.census.gov\/programs-surveys\/geography\/guidance\/geographic-areas-reference-manual.html"},{"key":"zoi200324r31","unstructured":"HealthCare.gov. High deductible health plan (HDHP). Accessed June 13, 2019. https:\/\/www.healthcare.gov\/glossary\/high-deductible-health-plan\/"},{"key":"zoi200324r32","unstructured":"Department of Health and Human Services. Patient Protection and Affordable Care Act; Actuarial Value Calculator Methodology. Accessed April 1, 2020. https:\/\/www.cms.gov\/CCIIO\/Resources\/Files\/Downloads\/av-calculator-methodology.pdf"},{"key":"zoi200324r33","unstructured":"Centers for Disease Control and Prevention. NCHS Urban-Rural Classification Scheme for Counties. Accessed June 29, 2019. https:\/\/www.cdc.gov\/nchs\/data_access\/urban_rural.htm"},{"key":"zoi200324r34","unstructured":"Centers for Disease Control and Prevention. HIV in the Southern United States. September 2019. Accessed December 13, 2019. https:\/\/www.cdc.gov\/hiv\/pdf\/policies\/cdc-hiv-in-the-south-issue-brief.pdf"},{"key":"zoi200324r35","unstructured":"US Census Bureau. The black population: 2010. September 2011. Accessed January 20, 2020. https:\/\/www.census.gov\/prod\/cen2010\/briefs\/c2010br-06.pdf"},{"key":"zoi200324r42","unstructured":"AIDS Foundation of Chicago. United Healthcare discriminates against vulnerable populations by denying PrEP access. August 4, 2017. Accessed January 20, 2020. https:\/\/www.aidschicago.org\/page\/news\/all-news\/united-health-care-discriminates-against-vulnerable-populations-by-denying-prep-access"},{"key":"zoi200324r45","unstructured":"American Medical Association. 2017 AMA Prior Authorization Physician Survey. Accessed June 28, 2019. https:\/\/www.ama-assn.org\/sites\/ama-assn.org\/files\/corp\/media-browser\/public\/arc\/prior-auth-2017.pdf"},{"key":"zoi200324r47","unstructured":"American Medical Association. 2018 Prior Authorization State Law Chart. Accessed December 13, 2019. https:\/\/www.ama-assn.org\/media\/22571\/download"},{"key":"zoi200324r48","unstructured":"US Preventive Services Task Force. Prevention of human immunodeficiency virus (HIV) infection: preexposure prophylaxis. June 11, 2019. Accessed December 13, 2019. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis"},{"key":"zoi200324r49","unstructured":"Andrews? M. Even when HIV prevention drug is covered, other costs block treatment. July 15, 2019. Accessed December 10, 2019. https:\/\/khn.org\/news\/even-when-hiv-prevention-drug-is-covered-other-costs-block-treatment\/"},{"key":"zoi200324r50","unstructured":"Centers for Medicare & Medicaid Services. Qualified health plan certification: information and guidance. Accessed January 20, 2020. https:\/\/www.qhpcertification.cms.gov\/s\/ReviewTools"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2766669\/mcmanus_2020_oi_200324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T13:01:12Z","timestamp":1591189272000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2766669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.7445","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]}}}